Company: HCWB
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-058961
Chunk: 33

Company: HCW Biologics Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 33
---
 the Company effected a one-for-forty reverse stock split of its common stock. Our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2024 that are incorporated by reference into this proxy are presented without giving effect to the reverse stock split. The shares in the above table reflect the one-for-forty reverse stock split of our common stock.

<div align='center'>23</div>

TABLE OF CONTENTS

EXECUTIVE OFFICERS Our executive officers and their ages as of April 22, 2025 and positions with HCW Biologics are provided in the table below and in the additional biographical descriptions set forth in the text below the table.

| Name                |     | Age |     | Position                                                           |
| Hing C. Wong, Ph.D. |     |  71 |     | Founder, Chief Executive Officer and Director                      |
| Rebecca Byam        |     |  69 |     | Chief Financial Officer                                            |
| Lee Flowers         |     |  79 |     | Senior Vice President of Business Development                      |
| Peter Rhode, Ph.D.  |     |  67 |     | Chief Scientific Officer and Vice President of Clinical Operations |

Our board of directors chooses our executive officers, who then serve at the discretion of our board of directors. Hing C. Wong, Ph.D. — For biographical information, see "Continuing Directors." Rebecca Byam has served as our Chief Financial Officer since October 2019. Prior to joining our company, Ms. Byam served as a Director of PricewaterhouseCoopers LLP from 2003 to 2019; the Chief Financial Officer of MaMaMedia Inc. from 1998 to 2002; the Chief Financial Officer of Momentum Partners from 1995 to 1998; and as an Investment Professional at Apax Partners LLP, where she specialized in biotechnology investments among other areas with strong intellectual property, from 1985 to 1995. Additionally, Ms. Byam served on the Investment Advisory Council, assisting the development of the Small Business Investment Company program of the U.S. Small Business Administration. Ms. Byam received a B.A. degree in liberal arts from Kenyon College and an M.B.A from the New York University Stern School of Business with a major in finance. She is currently registered as a Certified Public Accountant in the states of Florida and New York. Lee Flowers has served as our Senior Vice